Haloperidol Decanoate NDC 67457-410

NDC codes

FDA NDC Directory

Product NDC (as listed)67457-410Labeler and product segments. Claims need a package NDC.

Product NDC at billing width67457-0410Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
67457-410-13	67457041013	10 VIAL in 1 CARTON (67457-410-13) / 1 mL in 1 VIAL (67457-410-00)Marketed from Apr 23, 2013

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Haloperidol Decanoate
Generic name (nonproprietary): haloperidol decanoate
Active ingredients: Haloperidol decanoate — 50 mg/mL
Dosage form: Injection
Route: Intramuscular
Labeler: Mylan Institutional LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 075440
Marketing start: Apr 23, 2013
Listing expires: Dec 31, 2027
Identifiers: Product ID 67457-410_59ec8e4f-5adc-4342-add6-1357f5512cbdSPL ID 59ec8e4f-5adc-4342-add6-1357f5512cbdSPL set ID 8ffac6fb-1702-40d6-b085-152d24673cbdRxCUI 1719803, 1719862UNII AC20PJ4101
Pharmacologic class: Typical Antipsychotic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N467457041013 followed by a unit qualifier and the quantity

Package 67457-0410-13. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 15, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Haloperidol decanoate injection is indicated for the treatment of schizophrenia in adults who were previously taking a stable dosage of an immediate-release oral haloperidol product. Haloperidol decanoate injection is a typical antipsychotic indicated for the treatment of schizophrenia in adults who were previously taking a stable dosage of an immediate-release oral haloperidol product ( 1 ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 075440

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 075440
Product	Strength	Form · route	Labeler	Product NDC
Haloperidol Decanoate	Haloperidol decanoate 100 mg/mL	InjectionIntramuscular	Mylan Institutional LLC	67457-409